Lynn Mason: Taking Our Research at ASRM Beyond the Conference and Into Patient Care
Lynn Mason, Chief Executive Officer at Everleap Fertility and IVI Institute, shared on LinkedIn:
“Research matters most when it makes a difference in patient care.
As we head into American Society for Reproductive Medicine (ASRM) 2026, I’m proud that our team will be presenting 19 abstracts under our new name, Everleap Fertility, as part of IVI Institute, the global leader in reproductive medicine.
Read more about taking our research beyond the conference and into patient care.
Taking Our Research at ASRM Beyond the Conference and Into Patient Care.
I’m incredibly excited about attending the American Society for Reproductive Medicine (ASRM) 2026 conference, not just because our team will be presenting 19 abstracts, but because for the very first time, this great work will be presented under our new brand, Everleap Fertility.
The Everleap name is more than a symbol of a new chapter for our organization. It is an important component of making exceptional fertility care easier to understand, more connected, and more accessible to the people we care for.
Conferences like ASRM bring clinicians and researchers together to share discoveries and learn from one another. But progress depends on what happens next- evaluating new evidence and putting it into practice in ways that make a meaningful difference for patients.
Across Everleap Fertility’s more than 85 clinics and IVF laboratories in the U.S., we share a responsibility to bring new advancements into everyday care, so patients benefit from the research we’ll present at ASRM and feel more confident as they build their families.
Our unified clinical network of more than 200 physicians and embryologists consistently share knowledge with one another and apply emerging evidence so that promising findings don’t stay within academic journals or conference presentations.
By connecting our teams’ expertise, we’re working to bring advances to patients sooner and reduce the uncertainty that so often comes with seeking fertility care.
As part of IVI Institute, the global leader in reproductive medicine, we’re connected to a broader community of scientific expertise and clinical experience that helps advance the field.
At Everleap Fertility, we believe advancing reproductive medicine requires a continued commitment to research and its application into patient care.
The abstracts being presented this week reflect our network’s expertise and dedication to advancing fertility care and improving our understanding of reproductive health.
We’re proud to contribute to this progress and remain focused on translating research into meaningful advances that help patients navigate their fertility journeys with greater confidence.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Oct 23, 2026, 17:34Breast Cancer Awareness Month: Supporting Women Through Every Journey – Egg Donor and Surrogate Solutions
-
Oct 23, 2026, 17:28Demián Glujovsky: What Happens to Fertility Patients Between Visits?
-
Oct 23, 2026, 17:21Stephen Parker Ellington: Empathetic Fertility Care Can Scale, Even When Your Team Can’t
-
Oct 23, 2026, 17:16ACOG Releases New Guidance on the Use of GLP-1s in Pregnancy and Lactation
-
Oct 23, 2026, 17:06Emad Sedeek: ESHRE Recommendations on Good Practice in the IVF Laboratory 2026 – Part 2
-
Oct 23, 2026, 16:59Nitiz Murdia: Guiding You Through IVF – Your Journey’s Pilot
-
Oct 23, 2026, 16:56Ben Peipert: Come See My Poster Presentation at ASRM 2026
-
Oct 23, 2026, 16:50New RBMO Review Examines Benefits and Risks of Freeze-All IVF Strategies Across Ovarian Response Groups
-
Oct 23, 2026, 16:381 Week and Counting to the Next Campus Course on Male Infertility – ESHRE